Clearmind MedicineCMND
那斯達克 · USD
5.87
-0.13
(-2.17%)
收盤 10/24 03:47 (UTC+8)
10/24 03:47 (UTC+8)
Clearmind MedicineCMND
5.87
-0.13
(-2.17%)
財務數據
損益表
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- -
- 營業收入(億)
- 季增長率(%)
單位：美元千元
2026/Q2 | 2026/Q1 | 2025/Q4 | 2025/Q3 | 2025/Q2 | 2025/Q1 | 2024/Q4 | 2024/Q3 | 2024/Q2 | 2024/Q1 | |
營業收入淨額 | - | - | - | - | - | - | - | - | - | - |
營業成本 | - | - | - | - | - | - | - | - | - | - |
營業毛利 | - | - | - | - | - | - | - | - | - | - |
營業費用 | 2,180 | 1,571 | 3,660 | 1,456 | 1,408 | 1,307 | 1,496 | 1,586 | 1,471 | 1,304 |
研發費用 | 589 | 647 | 640 | 420 | 723 | 452 | 461 | 486 | 346 | 323 |
推銷及管理費用 | 1,591 | 925 | 3,019 | 998 | 685 | 855 | 1,035 | 1,060 | 1,125 | 981 |
非經常性項目費用 | - | - | - | - | - | - | - | - | - | - |
其他營業費用 | - | - | - | - | - | - | - | - | - | - |
營業利益 | -2,180 | -1,571 | -3,660 | -1,456 | -1,408 | -1,307 | -1,496 | -1,586 | -1,471 | -1,304 |
其他收入及費用 | - | - | - | - | - | - | - | - | - | - |
利息費用 | 5 | 4 | 4 | -6 | 9 | 8 | 9 | - | 61 | - |
稅前純益 | -904 | -2,044 | -3,851 | -686 | -1,305 | -763 | -1,032 | -788 | -2,051 | -871 |
所得稅 | 3 | 3 | 4 | 2 | 8 | 21 | 39 | 97 | 43 | 37 |
稅後純益 | -907 | -2,048 | -3,855 | -688 | -1,314 | -784 | -1,072 | -885 | -2,094 | -908 |
基本每股稅後盈餘(元) | -0.57 | -0.68 | -3.32 | - | -0.24 | -0.16 | -0.24 | - | -0.59 | -0.28 |
稀釋每股稅後盈餘(元) | -0.57 | -0.68 | -3.32 | - | -0.24 | -0.16 | -0.24 | - | -0.59 | -0.28 |
基本平均股數(千股) | 1582.00 | 3019.00 | 1162.00 | - | 5432.00 | 5035.00 | 4488.00 | - | 3559.00 | 3253.00 |
稀釋平均股數(千股) | 1582.00 | 3019.00 | 1162.00 | - | 5432.00 | 5035.00 | 4488.00 | - | 3559.00 | 3253.00 |
還原基本每股稅後盈餘(元) | -4.56 | -54.24 | -265.60 | - | -773.76 | -498.24 | -764.16 | - | -1888.00 | -896.00 |
還原稀釋每股稅後盈餘(元) | -4.56 | -54.24 | -265.60 | - | -773.76 | -498.24 | -764.16 | - | -1888.00 | -896.00 |
還原基本平均股數(千股) | 197 | 37 | 14 | - | 1 | 1 | 1 | - | 1 | 1 |
還原稀釋平均股數(千股) | 197 | 37 | 14 | - | 1 | 1 | 1 | - | 1 | 1 |
EBITDA(千元) | -885 | -2,027 | -3,834 | -679 | -1,284 | -743 | -1,012 | -776 | -1,975 | -855 |